Please use this identifier to cite or link to this item: https://repositorio.uca.edu.ar/handle/123456789/13637
Título : Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation
Autor : Brusco, Luis I. 
Cruz, Pablo 
Cangas, Alicia V. 
González Rojas, Carmen 
Vigo, Daniel Eduardo 
Cardinali, Daniel Pedro 
Palabras clave : CRONOBIOLOGIAMELATONINACOVID-19PANDEMIANEUMONIASUEÑO
Fecha de publicación : 2021
Editorial : Biolife LLC
Cita : Cardinali, D. P., Vigo, D. E., Brusco, L. I. et al. Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation [en línea]. Melatonin Res. 2021, 4 (1). doi: 10.32794/mr11250089. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/13637
Resumen : Abstract: The association of sleep disruption with a higher vulnerability to COVID-19 infection is a subject of major clinical importance. In patients with pneumonia associated with COVID-19 admitted to non-intensive care unit (NICU) several factors, like the disrupting influence of respiratory distress, medication, greater stress due to social isolation, and lack of appropriate exposure to environmental light can be instrumental to disrupt sleep/wake cycle. The therapeutic potential of melatonin to counteract the consequences of COVID-19 infection has been advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could be unique in impairing the consequences of SARS-CoV-2 infection. Melatonin is also an effective chronobiotic agent to reverse the circadian disruption of social isolation and to control delirium in severely affected patients. Properly administered, melatonin may restore the optimal circadian pattern of the sleep-wake cycle and improve clinical condition in pneumonia associated with COVID-19 patients. The present review article discusses the importance of maintaining normal sleep and circadian rhythmicity in NICU patients and provides preliminary data suggesting the efficacy of melatonin (9 mg/day) to reduce length of stay of pneumonia patients associated with COVID-19 in NICU.
URI : https://repositorio.uca.edu.ar/handle/123456789/13637
ISSN : 2641-0281 (on line)
Disciplina: MEDICINA
DOI: 10.32794/mr11250089
Derechos: Acceso abierto
Appears in Collections:Artículos

Files in This Item:
File Description SizeFormat
efficacy-melatonin-non-intensive.pdf343,83 kBAdobe PDFThumbnail
View/Open
Show full item record

Page view(s)

17
checked on Aug 9, 2022

Download(s)

7
checked on Aug 9, 2022

Google ScholarTM

Check


Altmetric


This item is licensed under a Creative Commons License Creative Commons